SK
Sanjay Koul
About Sanjay Koul
Data last updated:
Sanjay Koul is a Director at Bradina Aaronalis Pharmaceuticals Private Limited (since 2021). The company operates in Healthcare. Bradina Aaronalis Pharmaceuticals Private Limited reported revenue of ₹91.8 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 11 Sep 2021 | 2021 | ₹91.8 Lakh (FY 2024) | Active |
Board colleagues of Sanjay Koul
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amrinder Singh | 09622892 | Bradina Aaronalis Pharmaceuticals Private Limited | Director |
| Pardeep Singh | 05115068 | Bradina Aaronalis Pharmaceuticals Private Limited | Director |
| Varinder Kumar | 09315160 | Bradina Aaronalis Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanjay Koul
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanjay Koul
Sanjay Koul currently holds 1 directorship: Bradina Aaronalis Pharmaceuticals Private Limited (Director, since 11 Sep 2021, revenue ₹91.8 Lakh (FY 2024)).
Sanjay Koul was first appointed on 11 Sep 2021 as Director at Bradina Aaronalis Pharmaceuticals Private Limited.
The current boards of Sanjay Koul's companies include Amrinder Singh (Bradina Aaronalis Pharmaceuticals Private Limited), Pardeep Singh (Bradina Aaronalis Pharmaceuticals Private Limited), Varinder Kumar (Bradina Aaronalis Pharmaceuticals Private Limited).